Roquinimex-mediated protection effect on the development of chronic graft-versus-host disease in mice is associated with induction of Th1 cytokine production and inhibition of proinflammatory cytokine production

Life Sciences

Volumn 81, Issue 19-20, 2007, Pages 1403-1410

  Xiao, Zhi Yong ^a   Zhou, Wen Xia ^a   Zhang, Yong Xiang ^a   Cheng, Jun Ping ^a   He, Jun Feng ^a   Yang, Ri Fang ^a   Yun, Liu Hong ^a  

^a BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

Author keywords

Cytokine; Graft versus host disease; Macrophage; Roquinimex; Th1 Th2

Indexed keywords

CONCANAVALIN A; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 1BETA; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; ROQUINIMEX; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; GLOMERULONEPHRITIS; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; IMMUNOGLOBULIN DEPOSITION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MOUSE; NEPHRITIS; NONHUMAN; PERITONEUM MACROPHAGE; PROTEINURIA; SPLEEN CELL; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, ANTINUCLEAR; BLOOD UREA NITROGEN; CELLS, CULTURED; CHOLESTEROL; CHRONIC DISEASE; CREATININE; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT VS HOST DISEASE; HYDROXYQUINOLINES; IMMUNOGLOBULIN G; INFLAMMATION MEDIATORS; KIDNEY; MACROPHAGES; MALE; MICE; MICE, INBRED DBA; PROTEINURIA; SPLEEN; TH1 CELLS; TH2 CELLS; TRIGLYCERIDES;

ANIMALIA; MUS;

EID: 35548983874     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.08.044     Document Type: Article

References (41)

1. Abbas A.K., Murphy K.M., and Sher A. Functional diversity of helper T lymphocytes. Nature 383 (1996) 787-793
2. Andrei C., Dazzi C., Lotti L., Torrisi M.R., Chimini G., and Rubartelli A. The secretory route of the leaderless protein interleukin 1b involves exocytosis of endolysosome-related vesicles. Molecular Biology of the Cell 10 (1999) 1463-1475
3. Arbel I., Chezen E., Abramsky O., Karpati T., Ovadia H., Mizrachi-Koll R., and Karussis D. Linomide induces apoptotic death of cortical CD4/CD8 double positive thymocytes and thymic atrophy by a corticosteroid-independent pathway. Clinical Immunology 90 1 (1999) 108-114
4. Aringer M., and Smolen J.S. Cytokine expression in lupus kidneys. Lupus 14 (2005) 13-18
5. Bai X.F., Shi F.D., Zhu J., Xiao B.G., Hedlund G., and Link H. Linomide-induced suppression of experimental autoimmune neuritis is associated with down-regulated macrophage functions. Journal of Neuroimmunology 76 (1997) 177-184
6. Bengtsson M., Simonsson B., Carlsson K., Nilsson B., Smedmyr B., Termander B., Oberg G., and Totterman T.H. Stimulation of NK cell, T cell, and monocyte functions by the novel immunomodulator linomide after autologous bone marrow transplantation. A pilot study in patients with acute myeloid leukemia. Transplantation 53 (1992) 882-888
7. Blatt N.B., and Glick G.D. Anti-DNA autoantibodies and systemic lupus erythematosus. Pharmacology & Therapeutics 83 (1999) 125-139
8. Boswell J.M., Yui M.A., Burt D.W., and Kelley V.E. Increased tumor necrosis factor and IL-1b gene expression in the kidneys of mice with lupus nephritis. Journal of Immunology 141 (1988) 3050-3054
9. Boswell J.M., Yui M.A., Endres S., Burt D.W., and Kelley V.E. Novel and enhanced IL-1 gene expression in autoimmune mice with lupus. Journal of Immunology 141 (1988) 118-124
10. Bruijn J.A., Bergijk E.C., de Heer E., Fleuren G.J., and Hoedemaeker P.J. Induction and progression of experimental lupus nephritis: exploration of a pathogenetic pathway. Kidney International 41 (1992) 5-13
11. Coffman R.L., Lebman D.A., and Rothman P. Mechanism and regulation of immunoglobulin isotype switching. Advances in Immunology 54 (1993) 229-270
12. Dahlén E., Dawe K., Ohlsson L., Hall H., Hedse K., Annersten K., Åström M., Gross D.J., and Hedlund G. Linomide inhibits insulitis and modulates cytokine production in pancreatic islets in the nonobese diabetic mouse. International Immunopharmacology 3 (2003) 17-30
13. De Carli M., D'Elios M.M., Zancuoghi G., Romagnani S., and Del Prete G. Human Th1 and Th2 cells: functional properties, regulation of development and role in autoimmunity. Autoimmunity 18 (1994) 301-308
14. De Wit D., Van Mechelen M., Zanin C., Doutrelepont J.M., Velu T., Gerard C., Abramowicz D., Scheerlinck J.P., De Baetselier P., and Urbain J. Preferential activation of Th2 cells in chronic graft-versus-host reaction. Journal of Immunology 150 (1993) 361-366
15. Diab A., Michael L., Wahren B., Deng G.M., Björk J., Hedlund G., and Zhu J. Linomide suppresses acute experimental autoimmune encephalomyelitis in Lewis rats by counter-acting the imbalance of pro-inflammatory versus anti-inflammatory cytokines. Journal of Neuroimmunology 85 (1998) 146-154
16. Feng Y.H., Zhou W.L., Wu Q.L., Li X.Y., Zhao W.M., and Zou J.P. Low dose of resveratrol enhanced immune response of mice. Acta Pharmacologica Sinica 23 10 (2002) 893-897
17. Hagiwara E., Okubo T., Aoki I., Ohno S., Tsuji T., Ihata A., Ueda A., Shirai A., Okuda K., Miyazaki J., and Ishigatsubo Y. IL-12-encoding plasmid has a beneficial effect on spontaneous autoimmune disease in MRL/MP-lpr/lpr mice. Cytokine 12 (2000) 1035-1041
18. He J.F., Yun L.H., Yang R.F., Xiao Z.Y., Cheng J.P., Zhou W.X., and Zhang Y.X. Design, synthesis, and biological evaluation of novel 4-hydro-quinoline-3-carboxamide derivatives as an immunomodulator. Bioorganic & Medicinal Chemistry Letters 15 (2005) 2980-2985
19. High S. Protein translocation at the membrane of the endoplasmic reticulum. Progress in Biophysics and Molecular Biology 63 (1995) 233-250
20. Hogquist K.A., Nett M.A., Unanue E.R., and Chaplin D.D. Interleukin 1 is processed and released during apoptosis. Proceedings of the National Academy of Sciences of the United States of America 88 (1991) 8485-8489
21. Ishisaka R., Sato N., Tanaka K., Takeshige T., Iwata H., Klostergaard J., and Utsumi T. A part of the transmembrane domain of pro-TNF can function as a cleavable signal sequence that generates a biologically active secretory form of TNF. Journal of Biochemistry (Tokyo) 126 (1999) 413-420
22. Karpati T., Karussis D., Abramsky O., Mizrahi-Koll R., Arbell I., and Ovadia H. Inhibition of experimental autoimmune neuritis by the immunomodulator linomide. Immunology Letters 63 3 (1998) 141-145
23. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Alternative Medicine Review 8 (2003) 223-246
24. Lindorfer M.A., Schuman T.A., Craig M.L., Martin E.N., and Taylor R.P. A bispecific dsDNA × monoclonal antibody construct for clearance of anti-dsDNA IgG in systemic lupus erythematosus. Journal of Immunological Methods 248 (2001) 125-138
25. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., and Coffmann R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. Journal of Immunology 136 (1986) 2348-2357
26. Nezlin R., Dayan M., Zinger H., and Mozes E. DNA levels in immune complexes circulating in mice with induced systemic lupus erythematosus. Immunology Letters 67 (1999) 85-90
27. Palade G. Intracellular aspects of the process of protein synthesis. Science 189 (1975) 347-358
28. Peltoniemi J., Setälä N., Broberg E., Röyttä M., Hukkanen V., Salmi A.A., and Erälinna J.P. Semliki Forest virus infection is enhanced in Th1-prone SJL mice but not in Th2-prone BALB/c mice during linomide-induced immunomodulation. Journal of Neuroimmunology 132 (2002) 83-92
29. Rubartelli A., Cozzolino F., Talio M., and Sitia R. A novel secretory pathway for interleukin-1b, a protein lacking a signal sequence. Embo Journal 9 (1990) 1503-1510
30. Rus V., Svetic A., Nguyen P., Gause W., and Via C. Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease. Regulatory role of donor CD8+ T cells. Journal of Immunology 155 (1995) 2396-2406
31. Scott P., Natovitz P., Coffman R.L., Pearce E., and Sher A. Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. Journal of Experimental Medicine 168 (1988) 1675-1684
32. Shalev M., Ko A., Gelderman M.P., Fortin E., Reed G., Slavin S., and Gery I. Multiformic modulation of endotoxin effects by linomide. Clinical Immunology 93 (1999) 250-255
33. Shorlemmer H.U., Dickneite G., Kanzy E.J., and Enssle K.H. Modulation of the immunoglobulin dysregulation in GVH- and SLE-like diseases by the murine IL-4 receptor (IL-4R). Inflammation Research 44 (1995) S194-S196
34. Takahashi S., Fossati L., Iwamoto M., Merino R., Motta R., Kobayakawa T., and Izui S. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. Journal of Clinical Investigation 97 (1996) 1597-1604
35. Tarkowski A., Gunnarsson K., Nilsson L.A., Lindholm L., and Stalhandske T. Successful treatment of autoimmunity in MRL/l mice with LS-2616, a new immunomodulator. Arthritis Rheumatoid 29 (1986) 1405-1409
36. Tarkowski A., Gunnarsson K., and Stalhandske T. Effects of LS-2616 administration upon the autoimmune disease of (NZB × NZW) F1 hybrid mice. Immunology 59 (1986) 589-594
37. Tsai C.Y., Wu T.H., Huang S.F., Sun K.H., Hsieh S.C., Han S.H., Yu H.S., and Yu C.L. Abnormal splenic and thymic IL-4 and TNF-alpha expression in MRL-lpr/lpr mice. Scandinavian Journal of Immunology 41 (1995) 157-163
38. Tsuji K., Spears G.W., Nakamura K., Tojo T., Seki N., Sugiyama A., and Matsuo M. Synthesis and antinephritic activities of quinoline-3-carboxamides and related compounds. Bioorganic & Medicinal Chemistry Letters 12 (2002) 85-88
39. Umland S.P., Razac S., Nahrebne D.Y., and Seymour B.W. Effects of in vivo administration of interferon (IFN)-γ, anti-IFN-γ, or anti-interleukin-4 monoclonal antibodies in chronic autoimmune graft-versus-host disease. Clinical Immunology and Immunopathology 63 (1992) 66-73
40. Via C.S., Sharrow S.O., and Shearer G.M. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-versus-host disease. Journal of Immunology 139 (1987) 1840-1849
41. Weiss L., Barak V., Zeira M., Abdul-Hai A., Raibstein I., Reich S., Hirschfeld E., Gross D.J., and Slavin S. Cytokine production in linomide-treated NOD mice and the potential role of a Th1/Th2 shift on autoimmune and anti-inflammatory processes. Cytokine 19 (2002) 85-93